Vijay Yabannavar
Geen lopende functies
Profiel
Vijay Yabannavar worked as the VP-Process Development & Manufacturing at Emergent Product Development Seattle from 2007 to 2010.
He then held the position of SVP-Manufacturing & Technical Development at Emergent BioSolutions, Inc. After that, he worked as the Chief Manufacturing & Technical Operations Officer at Gritstone bio, Inc. Dr. Yabannavar holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the Indian Institute of Technology Bombay.
Eerdere bekende functies van Vijay Yabannavar
| Bedrijven | Functie | Einde |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01-01-2010 |
| EMERGENT BIOSOLUTIONS INC. | Chief Tech/Sci/R&D Officer | - |
| GRITSTONE BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Vijay Yabannavar
| Massachusetts Institute of Technology | Doctorate Degree |
| Indian Institute of Technology Bombay | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
